Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, announced that its shareholders approved all motions on the agenda of the AGM 2020.
March 31, 2020
· 6 min read